Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Giulino-Roth

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Blood|July 7, 2018
How I treat primary mediastinal B-cell lymphomaLisa Giulino-Roth
Leukemia & Lymphoma|November 20, 2014
EZH2: a potential new target in T-cell lymphoma?Lisa Giulino-Roth
Blood|July 13, 2023
Pembrolizumab in PMBCL: can it go the distance?Lisa Giulino-Roth
British Journal of Haematology|March 22, 2016
Recent molecular and therapeutic advances in B-cell non-Hodgkin lymphoma in childrenLisa Giulino-Roth, Stanton Goldman
Pediatric Blood & Cancer|June 10, 2023
Do no harm: Distinguishing between rebound thymic hyperplasia and Hodgkin lymphoma relapse in childrenNitya Gulati, Lisa Giulino-Roth
Blood|December 4, 2025
On the CHOPping block? Rethinking initial therapy for PMBCLNitya Gulati, Lisa Giulino-Roth
Blood|March 19, 2026
How can we safely eliminate RT in pediatric HL?Jaclyn Rosenzweig, Lisa Giulino-Roth
Current Hematologic Malignancy Reports|March 17, 2021
AYA Considerations for Aggressive LymphomasGabriela Llaurador, Lisa Giulino-Roth
Leukemia & Lymphoma|June 12, 2015
Reducing radiation exposure in children with febrile neutropenia: can pulmonary MRI replace CT?Sara Zarnegar, Lisa Giulino-Roth
Transplantation and Cellular Therapy|November 1, 2023
Relapsed/Refractory Primary Mediastinal B-cell Lymphoma: Where do we Stand?Nitya Gulati, Lisa Giulino-Roth
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Blood|July 7, 2018
How I treat primary mediastinal B-cell lymphomaLisa Giulino-Roth
Leukemia & Lymphoma|November 20, 2014
EZH2: a potential new target in T-cell lymphoma?Lisa Giulino-Roth
Blood|July 13, 2023
Pembrolizumab in PMBCL: can it go the distance?Lisa Giulino-Roth
British Journal of Haematology|March 22, 2016
Recent molecular and therapeutic advances in B-cell non-Hodgkin lymphoma in childrenLisa Giulino-Roth, Stanton Goldman
Pediatric Blood & Cancer|June 10, 2023
Do no harm: Distinguishing between rebound thymic hyperplasia and Hodgkin lymphoma relapse in childrenNitya Gulati, Lisa Giulino-Roth
Blood|December 4, 2025
On the CHOPping block? Rethinking initial therapy for PMBCLNitya Gulati, Lisa Giulino-Roth
Blood|March 19, 2026
How can we safely eliminate RT in pediatric HL?Jaclyn Rosenzweig, Lisa Giulino-Roth
Current Hematologic Malignancy Reports|March 17, 2021
AYA Considerations for Aggressive LymphomasGabriela Llaurador, Lisa Giulino-Roth
Leukemia & Lymphoma|June 12, 2015
Reducing radiation exposure in children with febrile neutropenia: can pulmonary MRI replace CT?Sara Zarnegar, Lisa Giulino-Roth
Transplantation and Cellular Therapy|November 1, 2023
Relapsed/Refractory Primary Mediastinal B-cell Lymphoma: Where do we Stand?Nitya Gulati, Lisa Giulino-Roth
Pageof 6